Corbus Pharmaceuticals
Corbus Pharmaceuticals Logo
About Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat serious diseases, including cancer, inflammatory, and fibrotic conditions. Its pipeline includes CRB-701, an antibody drug conjugate targeting Nectin-4 on cancer cells; CRB-601, an anti-integrin monoclonal antibody for solid tumors; and CRB-913, a cannabinoid type-1 receptor inverse agonist for obesity. The company has licensing agreements to expand its portfolio and holds multiple issued and pending patents. Corbus Pharmaceuticals serves markets in Europe, Israel, and Australia, and is headquartered in Norwood, Massachusetts.
Address
500 River Ridge Drive,
Norwood, 02062
United States
Year founded
2013
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
